A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC). (Q38392841)
Jump to navigation
Jump to search
scientific article published on 07 May 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC). |
scientific article published on 07 May 2016 |
Statements
1 reference
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC). (English)
1 reference
John D Hainsworth
1 reference
James A Reeves
1 reference
Joseph R Mace
1 reference
Edward J Crane
1 reference
Oday Hamid
1 reference
John R Stille
1 reference
Amy Flynt
1 reference
Stephanie Roberson
1 reference
John Polzer
1 reference
Edward R Arrowsmith
1 reference
7 May 2016
1 reference
1 reference
11
1 reference
5
1 reference
643-653
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference